The Food and Drug Administration, or FDA on Thursday announced that it had approved Gilead Sciences’ remdesivir as a coronavirus treatment. Following the announcement, shares of Gilead we...
Shares of cancer drugmaker Immunomedics doubled after Gilead Sciences announced on Sunday that it will acquire the company for $21 billion, or $88 per share in cash.In pre-market trading on Monday, Im...
Gilead Science Remdesivir coronavirus treatment cost. Keynote:Patients treated under government programs will pay $2,340Patients with private insurance will pay $3,120 A couple of months ago...
On Friday, President Trump announced that the remdesivir, an antiviral treatment developed by Gilead Sciences, had been authorized by the Food and Drug Administration (FDA) as an emergency treatment f...
When the COVID-19 pandemic recently broke out in the US, a few pharmaceuticals took it upon themselves to develop a vaccine or treatment for the coronavirus, and Gilead Sciences was one of the fore-ru...
Gilead Sciences, Moderna, 3M, RegeneronAmidst the coronavirus surge and the recent stock market plummet, while stocks like Apple (APPL) and Tesla (TSLA) fall, certain Biotech companies’ stocks perfo...